Connect with us

Technology

Axtria Leads Frost & Sullivan’s First Pharmaceutical Commercialization Solutions and Services Industry Radar Report

Published

on

BERKELEY HEIGHTS, N.J., Dec. 12, 2024 /PRNewswire/ — Axtria Inc., a global cloud software and data analytics company for the life sciences industry, is proud to announce its position as the leader in Frost & Sullivan’s inaugural Pharmaceutical Commercialization Solutions and Services Industry Radar Report. This recognition highlights Axtria’s unmatched innovation and growth in the pharmaceutical commercialization domain.

“Axtria’s relentless focus on innovation and sustainable growth continues to set it apart as a leading commercial solutions and services provider. By leveraging advanced data science and cloud-based analytics platforms, Axtria is empowering pharmaceutical companies to optimize commercialization operations and enhance patient outcomes globally,” said Aarti Chitale, Frost & Sullivan.

According to Frost & Sullivan, Axtria leads in this report, which measures companies using two key indices:

Growth Index (GI): A company’s performance and ability to execute a robust growth strategy.Innovation Index (II): The development of globally relevant, customer-aligned solutions addressing disruptive megatrends.

“At Axtria, our mission is to become the most admired data analytics company, empowering the global life sciences industry to achieve unprecedented levels of efficiency and effectiveness. We are proud to be recognized as a leader in Frost & Sullivan’s inaugural Pharmaceutical Commercial Solutions and Services Industry Radar Report. This acknowledgment underscores our commitment to innovation, harnessing technologies like AI to fuel advancements that transform operations, enable smarter decisions, and enhance patient outcomes, ultimately shaping the future of healthcare,” said Jassi Chadha, President and CEO of Axtria.

Key Report Highlights Include:

Innovation Excellence – Axtria’s innovative leveraging of data science and cloud-based analytics platforms empowers life sciences companies to enhance patient outcomes. Its suite of platforms—including Axtria DataMAx, Axtria InsightsMAx, Axtria SalesIQ, Axtria CustomerIQ, and Axtria MarketingIQ—streamlines data utilization, enabling pharmaceutical companies to optimize sales, marketing, and end-to-end commercial operations.

Sustainable Growth Leadership – With operations in more than 70 countries and a team of over 3,800 professionals, Axtria achieves annual double-digit growth. Recent expansions include:

New Global Innovation Centers: Recently, Axtria expanded its headquarters in New Jersey and inaugurated its 10th center in Hyderabad, India.Expanding Workforce: Axtria plans to grow its employee base by over 1,000, focusing on roles in data science, software development, and data engineering.Global Footprint: Recent expansions underscore Axtria’s commitment to scaling operations and supporting global healthcare innovation.

Recognition and Strategic Initiatives – Axtria’s focus on thought leadership and knowledge sharing continues to strengthen its brand recall. In June 2024, the company hosted over 350 senior leaders from 65 top pharmaceutical organizations at Axtria Ignite, where they discussed key industry topics such as patient engagement, generative AI, and omnichannel orchestration. This strategic focus positions Axtria as a pioneer in transforming pharmaceutical commercialization operations through technology.

Axtria provides complimentary access to the full report, which can be found here.

About Axtria’s Products and Solutions
Axtria is proud to work with 16 of the top 20 life sciences companies, globally. From our roots as a trusted consultant to our status as one of the world’s leading providers of cloud-based pharmaceutical management software, Axtria powers digital transformations in life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria InsightsMAx™ helps everyone from the C-suite to junior associates uncover trends to make better decisions. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration.

About Axtria
Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We’re proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit www.axtria.com.

Logo – https://mma.prnewswire.com/media/2256316/Axtria_transparent_bg_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/axtria-leads-frost–sullivans-first-pharmaceutical-commercialization-solutions-and-services-industry-radar-report-302329767.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bright Lights, Warm Nights: BLUETTI Portable Power Stations Bring Christmas Delight

Published

on

By

Keep the magic of Christmas alive with BLUETTI —powering every moment, wherever the season takes you.

LAS VEGAS, Dec. 12, 2024 /PRNewswire/ — Santa Claus is flying with magic power, and people with BLUETTI portable power station, are powering their most cherished Christmas. From cozy homes during winter storms to festive outdoor gatherings and seamless travels, reliable energy keeps the holiday joy alive. With BLUETTI’s portable power solutions, every moment shines as brightly as the season.

Family Moment with Warmer Powered Home

Nothing captures the Christmas spirit like family moments, yet the recent winter storms and outages can disrupt them. Amid these seasonal hurdles, BLUETTI Home Backup Battery ensures warmth and power, preserving the holiday magic.

With a powerful 3,000W output from the AC300 and 5,000W from the AC500, these home backup batteries power heaters and A/Cs effortlessly, making home cozy for gatherings and Christmas specials.

In the kitchen, the AC500 + 2*B300K supports the demands of a family feast. With 5529.6 Wh capacity and 16 versatile outlets, it provides ample energy for ovens to prepare holiday favorites, from golden roasted turkey to delicate cookies and cakes. While for those opting for a more understated celebration, the AC300 + B300K (2,764.8Wh capacity) powers a 600W microwave for over 4 hours, supporting effortless meal preparation for reheating or defrosting.

Bluetti AC300+B300K Home Backup Battery– now at $1,599 (36% off)
Bluetti AC500+ 2*B300K Home Backup Battery– now at $3,099 (23% off)

Outdoor Christmas Celebrations with Safer Power

From illuminating a Christmas market stall to powering winter outdoor adventures, BLUETTI’s reliable outdoor power keeps the festivities flowing safely.

Whether powering Christmas lights, playing music, charging phones, or running portable Wi-Fi, the Bluetti Elite200 V2 Portable Power Station is perfect for Christmas market-goers. Equipped with a durable EV-grade LiFePO4 battery capable of over 6,000 cycles, it ensures long-term reliability. With a 2,073.6Wh capacity and 2,600W output, it can power up to 9 devices simultaneously and handle up to 3,900W, keeping market lights, speakers, and hot beverage stations running smoothly and safely.

Or extend the joy of Christmas to snowy landscapes with the reliable BLUETTI AC200L + B300K for ice fishing, winter camping, or pursuing snow photography. Its impressive 2,400W output (3,600W surge) and 4,812.8Wh capacity ensure powering essential tools like portable heaters, cooking equipment, and even an electric saw—perfect for Christmas Tree Cutting.

Bluetti Elite 200 V2 Solar Generator– now at $1,099 (45% off)
Bluetti AC200L Portable Power Station– now at $1,099 (45% off)
Bluetti AC200L + B300K Expansion Battery– now at $2,298 (34% off)

Fully Charged on Christmas Travels  

For those embarking on Christmas road trips or visiting family during the holiday, portable energy solutions such as the AC180 and AC70 provide peace of mind.

For holiday road trips, the AC180 Solar Generator is built with 1,152Wh capacity and 1,800W output, is ideal for on-the-go power, providing around 15 charges for laptops—perfect for streaming Christmas movies. Pair it with the BLUETTI Charger 1 Alternator Charger to boost charging speed by up to 6 times, making the most of power throughout road trips.

For lighter Christmas travel, the AC70 Solar Generator, featuring a 768Wh capacity and 1,000W output, provides just the right amount for powering essentials such as car fridges, electronics, and electric blankets, ensuring comfort during travel.

Bluetti AC180 Solar Generator – now at $499 (50% off)
Bluetti AC180 + Charger 1 Alternator Charger – now at $748 (50% off)
Bluetti AC70 Solar Generator – now at $379 (46% off)

Start 2025 with the Upgraded BLUETTI

This Christmas, elevate energy management with the upgraded BLUETTI APP. Real-time monitoring, along with new energy statistics, allows users to track consumption, reserves, and savings—making it easier to optimize energy habits and reduce costs for a more sustainable lifestyle. The newly OTA notifications also keep users up to date with the latest firmware version, ensuring battery system is always performing at its best.

As families gather this season, it’s the perfect time to move past 2024’s challenges and step into a brighter, more sustainable 2025. With BLUETTI’s dependable power solutions, the holiday magic remains uninterrupted—free from power outages, limited outlets, or drained batteries.

About BLUETTI

As a technology pioneer in clean energy, BLUETTI is committed to a sustainable future by providing affordable green energy storage solutions for both indoor and outdoor use. Through initiatives like the LAAF (Lighting An African Family) program, BLUETTI is dedicated to bringing power to 1 million African families in off-grid areas. With a strong focus on innovation and customer needs, BLUETTI has established itself as a trusted industry leader in over 110 countries and regions.

CONTACT: Ellen Lee, ellenlee@bluetti.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bright-lights-warm-nights-bluetti-portable-power-stations-bring-christmas-delight-302330174.html

SOURCE BLUETTI POWER INC

Continue Reading

Technology

Therap Expands Reporting Capabilities with New Features to Support Better Management, Strengthen Compliance, and Enhance Person-Centered Care

Published

on

By

 TORRINGTON, Conn., Dec. 12, 2024 /PRNewswire/ — Therap Services, the national leader in delivering HIPAA-compliant electronic documentation solutions for organizations in the Long-Term Services and Supports (LTSS), Home and Community-Based Services (HCBS) and broader human services sector, continues to refine its system capabilities. With its latest updates to the report library, Therap aims to streamline management, enhance visibility, and provide more accurate, actionable insights for service providers, furthering its commitment to quality care and efficient operations.

These recent updates focus on enhancing scheduling, incident tracking, and oversight reporting—key areas that play a crucial role in daily provider workflows. Therap has added features that allow for more effective tracking of schedules, especially when managing shift approvals and time zones, which are now aligned with an individual’s local time. Therap’s GER Interval Report has also been refined to include detailed review time tracking, offering a better view of incident timelines and improving oversight and response time.

Further updates have introduced enhancements to oversight and user detail reports. The addition of new columns for tracking specific developmental and intellectual disabilities aids organizations in meeting regulatory and program-specific requirements. Other updates, like the new “Signature Completed” status for user actions and expanded details for medication and individual data forms, simplify data entry and improve audit readiness. These improvements reflect Therap’s dedication to helping organizations achieve compliance with ease and efficiency.

Therap’s dedication to continuous improvement goes beyond technical upgrades; it represents a broader mission to support organizations with tools that meet the unique demands of the human services field. By making essential information more manageable, Therap enables service providers to allocate resources effectively, streamline reporting processes, and focus more on the individuals they serve. Each new feature in the report library highlights Therap’s role as a trusted partner, committed to remaining at the forefront of care management technology. These enhancements help organizations meet evolving standards in compliance, transparency, and Person-Centered support, empowering providers to deliver exceptional care with confidence.

For more information on Therap’s comprehensive e-Solution for Person-Centered services, please visit https://www.therapservices.net/products/comprehensive-esolution-for-person-centered-services/

About Therap

Therap’s comprehensive and HIPAA-compliant software is used in human services settings for documentation, communication, reporting, EVV and billing.

Learn more at www.therapservices.net

Related Links
http://www.therapservices.net

View original content:https://www.prnewswire.com/news-releases/therap-expands-reporting-capabilities-with-new-features-to-support-better-management-strengthen-compliance-and-enhance-person-centered-care-302330368.html

SOURCE Therap Services

Continue Reading

Technology

Abstrax Unveils All-Star Scientific Advisory Board to Drive Pioneering Research, Safety, and Product Innovations

Published

on

By

The Brainchild of Newly Appointed CEO Kevin Koby, the Scientific Advisory Board Features Top Experts from Different Industries

IRVINE, Calif., Dec. 12, 2024 /PRNewswire-PRWeb/ — Abstrax is thrilled to announce the formation of its Scientific Advisory Board, bringing together four distinguished experts whose diverse fields of expertise will guide the company’s continued innovation in botanically-derived terpenes, cannabis science, and beyond. This powerhouse team includes Barbara Taylor, an icon in flavor science; Antoine Lie, a celebrated perfumer redefining fragrance innovation; Dr. Willie McKinney, a regulatory, toxicology, and safety authority; and Dr. Avery Gilbert, a world-renowned smell scientist and sensory expert. Together, they provide a wealth of knowledge and mentorship that will bolster Abstrax’s efforts to set new standards in product development, sensorial experiences, and consumer safety.

“The fusion of our passion with the unparalleled expertise of our Scientific Advisory Board sets the stage for an exhilarating journey in flavor, scent and sensory exploration. As we push boundaries together, we’re ushering in a new era for Abstrax and the cannabis industry at large.” – Kevin Koby

Abstrax’s Scientific Advisory Board panel was conceived of by Kevin Koby, Co-Founder and newly appointed Chief Executive Officer of Abstrax.

“We’re ecstatic to welcome these four distinguished intellectuals with impressive legacies to our Scientific Advisory Board, to help leverage and direct our research and technologies to pioneer functional and experiential flavors and fragrances,” says Kevin Koby, Co-Founder and CEO of Abstrax. “Each member serves as a mentor and guide for the Abstrax team by providing decades of hands-on experience and knowledge. Venturing beyond 2024 and into 2025, our goal remains to amplify our reservoir of knowledge and refine our methodologies, ensuring we offer the pinnacle of products and services for the customers we serve.”

Barbara Taylor joins the panel to help bolster the Flavor Development Team and further its mission to lead the industry in experiential flavors, formulation consistency, and advanced product applications. As the Principal Flavorist for Altria for more than 26 years, she has created some of the most iconic flavors for leading fruit juice and inhalation brands. Go to almost any grocery store in the United States to find examples of her work. Her in-depth knowledge and propensity for innovation will undoubtedly continue raising the bar for Abstrax to offer the widest variety of experiential flavors for brands seeking to offer customers unique product experiences that create raving fans.

Dr. Avery Gilbert, a foremost sensory psychologist renowned for pioneering flavor and aroma research for major global corporations, is a key member of the Abstrax advisory panel, poised to lead groundbreaking scientific investigations. With his vast knowledge of human olfactory perception, Avery has helped to develop internal and external sensory panels for Abstrax product testing. Together, Abstrax developed and validated AI-based mood enhancing terpene blends (AI Terp Effects) for use as a functional ingredient in consumer products and they continue working to quantify the benefits of functional flavorings in beverages and CPG applications targeting mood. The brain behind “What the Nose Knows: The Science of Scent in Everyday Life”, Dr. Gilbert has immersed himself in exhaustive research both in academia and in R&D labs of global flavor and perfume corporations. Such was the resonance of his revolutionary findings that he secured a nomination for the Los Angeles Times Book Prize in Science and Technology and a spot in the shortlist for the Royal Society of Prize for Science Books.

Dr. Willie McKinney has been inducted into the Abstrax advisory framework, fortified with the task of strengthening the company’s regulatory and safety guidelines. Dr. McKinney and team have been an integral part of creating Abstrax RA-TEP (Risk Assessment-Toxicology Evaluation Program), the world’s most extensive and comprehensive cannabis ingredient study for establishing safety standards of inhalable ingredients and flavorings used in cannabis. It aims to finally establish the acceptable ingredient use levels for terpene-based flavors used in cannabis products, a novel approach that prioritizes consumer safety over all else. As the visionary CEO and Founder of McKinney Regulatory Science Advisors, LLC, he holds a board certification in toxicology from the American Board of Toxicology. Dr. McKinney also worked for many years with Altria navigating the Pre-Market Tobacco Applications and helped to architect the safety programs for Big Tobacco. Beyond authoring a plethora of peer-reviewed scholarly articles, Dr. McKinney has delivered presentations to a multitude of scientific bodies. His esteemed role extends to the FDA’s Tobacco Product Scientific Advisory Committee (TPSAC), where he represents the tobacco manufacturing sector in a non-voting capacity.

Antoine Lie is a celebrated French perfumer and is taking on a pivotal role on the advisory board. With a legacy of crafting iconic fragrances for luxury brands like Armani Code, Burberry, and Gucci at Givaudan, Antoine now lends his visionary prowess to Abstrax. He brings with him not just his scent-creating acumen but also his experience in translating scientific innovations into marketable fragrances. Motivated by a desire to transcend conventional boundaries and driven by the allure of Abstrax’s unique cannabis scents and AI terpene blends, Antoine is set to help the company push innovation to new heights.

Beyond the named panel members, Kevin Koby is the key panel organizer and serves as Chairman of the Board.

“The fusion of our passion with the unparalleled expertise of our Scientific Advisory Board sets the stage for an exhilarating journey in flavor, scent and sensory exploration. As we push boundaries together, we’re ushering in a new era for Abstrax and the cannabis industry at large,” says Kevin Koby.

For more information and further updates, please visit https://abstraxtech.com/pages/meet-the-team.

About Abstrax: Where Innovation and Science Meets Flavor Mastery

As the pioneering leader in the world of botanical flavor technology, Abstrax excels in crafting innovative terpene-driven, functional flavor solutions. Serving the cannabis, hops, flavor and fragrance industries, Abstrax is the trusted product development partner that forward-thinking CPG brands turn to when looking for a competitive edge. Founded in California by a team of award-winning PhD scientists, flavor chemists, and visionary product developers, Abstrax harnesses its divisions to craft transformative CPG applications via innovative technology and more sustainable, all natural, and cost effective ingredients. Abstrax Tech produces groundbreaking peer reviewed research publications, discovers new flavor compounds, and produces terpene blends and flavors for tobacco, cannabis, and food applications – including botanically derived cannabis flavor experiences, live all-natural hemp derived terpenes, and mood-enhancing terpene-flavor systems. Abstrax Hops provides the most advanced research, products, and services that push the limits of brewing innovation. Its wide range of solutions encapsulates the authentic varietal specific Hop Flavors, Dank Flavors, and next generation of advanced hop products including natural hop aroma extracts. Abstrax offers the utmost in safety, quality and regulatory adherence, ensuring seamless integration into product lines. Delve deeper with Abstrax at AbstraxTech.com and AbstraxHops.com.

Media Contact

Abstrax PR, Abstrax, 1 2139258177, stacey@lavozmarketing.com, https://www.abstraxtech.com 

View original content to download multimedia:https://www.prweb.com/releases/abstrax-unveils-all-star-scientific-advisory-board-to-drive-pioneering-research-safety-and-product-innovations-302330009.html

SOURCE Abstrax

Continue Reading

Trending